Top Markets
Coin of the day
Lumosa Therapeutics Co., Ltd. Lumosa Therapeutics Co., Ltd.

Lumosa Therapeutics Co., Ltd.

6535
Classement en actions #14754
Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company,... Lumosa Therapeutics Co., Ltd. is a clinical-stage pharmaceutical company, headquartered in Taiwan, focused on developing innovative therapies for neurological and oncological diseases. Its most advanced product, LT-1001, an injectable analgesic, has completed Phase III clinical trials for the management of severe post-operative pain. The company's pipeline also includes LT3001, currently in Phase II for treating acute ischemic stroke; LT5001, which has finished Phase Ib trials for uremic pruritus; and LT2003, an oncology drug candidate in its preclinical development stage. Founded in 2000, Lumosa Therapeutics maintains its operational base in Taipei.
Prix de l'action
$2.35
Capitalisation boursière
$394.12M
Changement (1 jour)
-1.07%
Changement (1 an)
-64.75%
Pays
TW
Échange Lumosa Therapeutics Co., Ltd. (6535)

Catégorie

Historique du prix de l'action pour Lumosa Therapeutics Co., Ltd. (6535)
Prix de clôture le plus élevé : $2.35 le 2026-09-01

Prix de clôture le plus bas : $1.29 le 2015-07-01
Historique du prix de l'action de Lumosa Therapeutics Co., Ltd. de 2015 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -11.24%
2025 -7.99%
2024 206.71%
2023 67.55%
2022 -8.12%
2021 11.91%
2020 4.84%
2019 18.82%
2018 1.29%
2017 -28.93%
2016 -36.03%
2015 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.37 -11.93%
AU
$138.80 476.17%
US
$746.00 4.56%
CH